🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
HanchorBio Inc. (TPE:7827)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
108.00
-11.50 (-9.62%)
At close: Nov 19, 2026

HanchorBio Statistics

Total Valuation

HanchorBio has a market cap or net worth of TWD 15.12 billion. The enterprise value is 14.00 billion.

Market Cap15.12B
Enterprise Value 14.00B

Important Dates

The next estimated earnings date is Friday, November 27, 2026.

Earnings Date Nov 27, 2026
Ex-Dividend Date n/a

Share Statistics

HanchorBio has 139.97 million shares outstanding. The number of shares has increased by 19.16% in one year.

Current Share Class 139.97M
Shares Outstanding 139.97M
Shares Change (YoY) +19.16%
Shares Change (QoQ) +7.40%
Owned by Insiders (%) 36.90%
Owned by Institutions (%) 7.44%
Float 79.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 546.49
PB Ratio 14.63
P/TBV Ratio 14.67
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.21.

Current Ratio 2.79
Quick Ratio 2.65
Debt / Equity 0.21
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -351.53

Financial Efficiency

Return on equity (ROE) is -115.12% and return on invested capital (ROIC) is -64.12%.

Return on Equity (ROE) -115.12%
Return on Assets (ROA) -52.37%
Return on Invested Capital (ROIC) -64.12%
Return on Capital Employed (ROCE) -107.50%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 221,296
Profits Per Employee -8.07M
Employee Count127
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax -1.22M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +60.95% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +60.95%
50-Day Moving Average 146.73
200-Day Moving Average 147.50
Relative Strength Index (RSI) 17.61
Average Volume (20 Days) 181,942

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HanchorBio had revenue of TWD 27.66 million and -1.01 billion in losses. Loss per share was -7.55.

Revenue27.66M
Gross Profit 1.80M
Operating Income -1.29B
Pretax Income -1.26B
Net Income -1.01B
EBITDA -1.26B
EBIT -1.29B
Loss Per Share -7.55
Full Income Statement

Balance Sheet

The company has 1.44 billion in cash and 237.48 million in debt, with a net cash position of 1.20 billion or 8.58 per share.

Cash & Cash Equivalents 1.44B
Total Debt 237.48M
Net Cash 1.20B
Net Cash Per Share 8.58
Equity (Book Value) 1.11B
Book Value Per Share 7.19
Working Capital 990.90M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -999.71 million and capital expenditures -40.00 million, giving a free cash flow of -1.04 billion.

Operating Cash Flow -999.71M
Capital Expenditures -40.00M
Depreciation & Amortization 28.10M
Net Borrowing 15.91M
Free Cash Flow -1.04B
FCF Per Share -7.43
Full Cash Flow Statement

Margins

Gross Margin 6.50%
Operating Margin -4,672.79%
Pretax Margin -4,540.81%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HanchorBio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -19.16%
Shareholder Yield -19.16%
Earnings Yield -6.99%
FCF Yield -6.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1